120 related articles for article (PubMed ID: 35802570)
1. Comparison of Seegene Anyplex II HPV28 assay with BD Onclarity HPV assay for human papillomavirus genotyping.
Kim M; Kim J; Park NJ; Park JY
PLoS One; 2022; 17(7):e0267836. PubMed ID: 35802570
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of Anyplex II HPV28 and Allplex HPV28 molecular assays for human papillomavirus detection and genotyping in anogenital cancer screening.
Naegele K; Bubendorf L; Hirsch HH; Leuzinger K
J Med Virol; 2024 Jun; 96(6):e29649. PubMed ID: 38812416
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework.
Bonde JH; Pedersen H; Quint W; Xu L; Arbyn M; Ejegod DM
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31723012
[TBL] [Abstract][Full Text] [Related]
4. HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples.
Cornall AM; Poljak M; Garland SM; Phillips S; Machalek DA; Tan JH; Quinn MA; Tabrizi SN
Papillomavirus Res; 2017 Dec; 4():79-84. PubMed ID: 29179874
[TBL] [Abstract][Full Text] [Related]
5. Anyplex II HPV test in detection and follow-up after surgical treatment of CIN2+ lesions.
Bottari F; Iacobone AD; Radice D; Preti EP; Preti M; Franchi D; Piana AF; Sandri MT; Passerini R
J Med Virol; 2021 Nov; 93(11):6340-6346. PubMed ID: 33565607
[TBL] [Abstract][Full Text] [Related]
6. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; Guimerà N; Torne A; Ordi J
J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
[TBL] [Abstract][Full Text] [Related]
8. Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples.
Bell M; Verberckmoes B; Devolder J; Vermandere H; Degomme O; Guimarães YM; Godoy LR; Ambrosino E; Cools P; Padalko E
Microbiol Spectr; 2023 Aug; 11(4):e0008123. PubMed ID: 37284753
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
Oštrbenk A; Xu L; Arbyn M; Poljak M
J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30209184
[TBL] [Abstract][Full Text] [Related]
10. Onclarity Performance in Human Papillomavirus DNA Detection in Formalin-Fixed Paraffin-Embedded Cervical Samples.
Bottari F; Passerini R; Renne G; Guerrieri ME; Sandri MT; Li A; Orlandini A; Iacobone AD
J Low Genit Tract Dis; 2021 Jul; 25(3):216-220. PubMed ID: 34176913
[TBL] [Abstract][Full Text] [Related]
11. Clinical Performance of the BD Onclarity Extended Genotyping Assay for the Management of Women Positive for Human Papillomavirus in Cervical Cancer Screening.
Volesky KD; Magnan S; Mayrand MH; Isidean SD; El-Zein M; Comète E; Franco EL; Coutlée F
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):851-857. PubMed ID: 35131879
[TBL] [Abstract][Full Text] [Related]
12. Comparative performance of various human papillomavirus assays available in Korea for detecting cervical intraepithelial neoplasia.
Ouh YT; Park JJ; Kang M; Kim M; Song JY; Shin SJ; Shim SH; Yoo HJ; Lee M; Lee SJ; Shin W; Chong GO; Choi MC; Choi CH; Min KJ
J Obstet Gynaecol Res; 2022 Jan; 48(1):207-214. PubMed ID: 34713538
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection.
Kwon MJ; Roh KH; Park H; Woo HY
J Clin Virol; 2014 Apr; 59(4):246-9. PubMed ID: 24568964
[TBL] [Abstract][Full Text] [Related]
14. Clinical performance of the BD Onclarity HPV assay using an adjudicated cohort of BD SurePath liquid-based cytology specimens.
Wright TC; Stoler MH; Agreda PM; Beitman GH; Gutierrez EC; Harris JM; Koch KR; Kuebler M; LaViers WD; Legendre BL; Leitch SV; Maus CE; McMillian RA; Nussbaumer WA; Palmer ML; Porter MJ; Richart GA; Schwab RJ; Vaughan LM
Am J Clin Pathol; 2014 Jul; 142(1):43-50. PubMed ID: 24926084
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Seegene Anyplex II Performance for Detection of Human Papillomavirus Genotypes in Formalin-Fixed, Paraffin-Embedded Cervical Cancer Specimens.
Haqshenas G; Molano M; Phillips S; Balgovind P; Garland SM; Hawkes D; Brotherton JM; Machalek DA; Murray G
Arch Pathol Lab Med; 2024 Mar; 148(3):353-358. PubMed ID: 37226838
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of HPV genotyping: A study on the performance concordance between Anyplex II HPV28 detection and Linear Array genotyping tests in nationwide studies in Brazil.
Bandeira IC; Comerlato J; Bessel M; Fernandes BV; Mota G; Villa LL; de Souza FMA; Pereira GFM; Wendland EM
PLoS One; 2024; 19(6):e0305122. PubMed ID: 38861542
[TBL] [Abstract][Full Text] [Related]
17. Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.
Cornall AM; Poljak M; Garland SM; Phillips S; Tan JH; Machalek DA; Quinn MA; Tabrizi SN
Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):545-551. PubMed ID: 27822653
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus genotype concordance between Anyplex II HPV28 and linear array HPV genotyping test in anogenital samples.
Coutlée F; de Pokomandy A; Burchell AN; El-Zein M; Mayrand MH; Rodrigues-Coutlée S; Money D; Comète É; McClymont E; Rouleau D; Franco EL
J Med Virol; 2022 Jun; 94(6):2824-2832. PubMed ID: 35060132
[TBL] [Abstract][Full Text] [Related]
19. HPV genotype-specific distribution and attributable risk in cervical intraepithelial neoplasia in a referral population with a history of LSIL.
Ratnam S; Jang D; Alaghehbandan R; Gilbert L; Xu Y; Wang W; Andrews P; Green A; Speicher DJ; Chernesky M
Cancer Biomark; 2023; 38(4):433-442. PubMed ID: 37980645
[TBL] [Abstract][Full Text] [Related]
20. High-risk human papillomavirus (HPV) detection in formalin-fixed paraffin-embedded cervical tissues: performances of Aptima HPV assay and Beckton Dickinson (BD) Onclarity assay.
Kir G; Gunel H; Olgun ZC; McCluggage WG
J Clin Pathol; 2023 Jan; 76(1):40-46. PubMed ID: 34376567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
